Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.
Clinical trial NCT04463771 · COMPLETED
Trial details
- NCT number
- NCT04463771
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-26
- Primary completion
- 2026-05-29
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.